Biochemical producer, GlycosBio, is building its first commercial facility in southern Malaysia. The 10.000 ton plant is expected to start-up this year and will be used to produce anhydrous ethanol and targeted biochemicals based on demand. GlycosBio’s bacterial fermentation platform can convert a variety of renewable, non-food feedstocks including crude glycerin from Southeast Asia and palm oil derivatives from the region into higher value biochemicals, such as bio-based synthetic isoprene monomer (Bio-SIM). Isoprene is a critical component of synthetic rubber and is globally in short supply. GlycosBio molecules for the synthetic rubber industry are reportedly drop-in replacement chemicals that integrate seamlessly into existing petrochemical supply chains and systems offering economic performance and cost benefits greater than those available from conventional petrochemical processes and Isoprene from sugar based feedstocks.
.“We think we’re approaching the market at the right scale for the opportunity with an initial capacity of 10 kilo tons per year . We think southern Malaysia is a good place to start this project. Beside feedstock, we have good market access and an overall sound business environment. There is respect for private property and IP rights and we feel we can safeguard our business interests there,” explained Robert Toker, Vice President, Partnerships and Market Planning, GlycosBio.